REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in March.
The audio portion of the presentation will be available on the investors’ page of the Coherus BioSciences website at http://investors.coherus.com.
About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.
For additional information, please visit www.coherus.com.
Contact
McDavid Stilwell
EVP, Financial Strategy and IR
Coherus BioSciences, Inc.
mstilwell@coherus.com
+1 (650) 395-0152
Calls for Contributions to Support Future Medical Device & Pharmaceutical Packaging LeadersArlington, Virginia--(Newsfile Corp. -…
Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…
Albe brings extensive immunology and translational research experience to his full-time role working with WRF's…
BOCA RATON, Fla., Dec. 10, 2025 /PRNewswire/ -- Omega Healthcare, a leading provider of technology-driven healthcare…
Industry collaboration leads to significant improvements in CY 2026 Final Rule but long-term stability remains…
Ohio patients empowered to compare prices, save on care, fight surprise bills COLUMBUS, Ohio,, Dec. 10,…